Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progressionLeonardo Delello Di Filippo, Marlus Chorilli, Juliana H. Azambuja et al.|International Journal of Pharmaceutics|2022Cited by 48